Evercore ISI Issues Positive Forecast for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLXFree Report) had its price objective raised by Evercore ISI from $145.00 to $155.00 in a research note issued to investors on Tuesday.

Several other equities analysts have also issued reports on the company. Barclays dropped their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. JPMorgan Chase & Co. raised their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday. Wells Fargo & Company increased their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Finally, DA Davidson upped their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $157.64.

Read Our Latest Stock Report on CLX

Clorox Stock Down 7.2 %

Shares of NYSE CLX opened at $148.29 on Tuesday. The company’s 50 day moving average price is $162.63 and its 200-day moving average price is $158.67. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. Clorox has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a market capitalization of $18.36 billion, a P/E ratio of 51.67, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period last year, the business earned $2.16 EPS. Equities analysts forecast that Clorox will post 6.86 earnings per share for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.29%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is currently 170.04%.

Institutional Investors Weigh In On Clorox

A number of institutional investors have recently added to or reduced their stakes in the company. Insight Folios Inc grew its holdings in shares of Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after acquiring an additional 63 shares in the last quarter. Integral Investment Advisors Inc. grew its stake in Clorox by 4.1% in the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock valued at $279,000 after purchasing an additional 67 shares during the period. HCR Wealth Advisors increased its position in shares of Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after purchasing an additional 68 shares during the last quarter. Empower Advisory Group LLC raised its stake in shares of Clorox by 4.5% during the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after purchasing an additional 78 shares during the period. Finally, Aviance Capital Partners LLC boosted its holdings in shares of Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after buying an additional 80 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.